MET in ovarian cancer: Metastasis and resistance?

per Tang, Chad, Jardim, Denis L, Hong, David
Publicat 2014

Recent results of immunotherapy and perspectives for advanced NSCLC

per Jardim, Denis L, de Melo Gagliato, Debora
Publicat a Lung Cancer Manag (2016)

Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities

per Jardim, Denis L Fontes, Conley, Anthony, Subbiah, Vivek
Publicat 2013

Noninvasive cancer biomarkers in solid malignancies: circulating tumor DNA—clinical utility, current limitations and future perspectives

per de Melo Gagliato, Debora, Fontes Jardim, Denis L.
Publicat a Ann Transl Med (2018)

Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology

per Jardim, Denis L., de Melo Gagliato, Débora, Kurzrock, Razelle
Publicat a Integr Cancer Ther (2018)

The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker

per Jardim, Denis L., Goodman, Aaron, Gagliato, Debora de Melo, Kurzrock, Razelle
Publicat a Cancer Cell (2020)

Analysis of Drug Development Paradigms for Immune Checkpoint inhibitors

per Jardim, Denis L., de Melo Gagliato, Débora, Giles, Francis J., Kurzrock, Razelle
Publicat a Clin Cancer Res (2017)

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis

per Ikeda, Sadakatsu, Schwaederle, Maria, Mohindra, Mandakini, Fontes Jardim, Denis L., Kurzrock, Razelle
Publicat a J Hematol Oncol (2018)

Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds

per Jardim, Denis L., De Melo Gagliato, Débora, Nikanjam, Mina, Barkauskas, Donald A., Kurzrock, Razelle
Publicat a Oncoimmunology (2020)

Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer

per Knebel, Franciele H., Bettoni, Fabiana, da Fonseca, Leonardo G., Camargo, Anamaria A., Sabbaga, Jorge, Jardim, Denis L.
Publicat a Front Oncol (2019)

Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large‐Scale Data to Inform Therapeutic Directions

per Jardim, Denis L., Millis, Sherri Z., Ross, Jeffrey S., Woo, Michelle Sue‐Ann, Ali, Siraj M., Kurzrock, Razelle
Publicat a Oncologist (2020)

Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics

per Jardim, Denis L., Millis, Sherri Z., Ross, Jeffrey S., Woo, Michelle Sue‐Ann, Ali, Siraj M., Kurzrock, Razelle
Publicat a Oncologist (2021)

Phosphatidylinositol 3‐kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities

per Millis, Sherri Z., Jardim, Denis L., Albacker, Lee, Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj M., Kurzrock, Razelle
Publicat a Cancer (2018)

Use of expansion cohorts in phase 1 trials and probability of success in phase 2 for 381 anticancer drugs

per Bugano, Diogo D. G., Hess, Kenneth, Jardim, Denis L. F., Zer, Alona, Meric-Bernstam, Funda, Siu, Lillian L., Razak, Albiruni, Hong, David S.
Publicat a Clin Cancer Res (2017)

Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval

per Fontes Jardim, Denis L., Schwaederle, Maria, Wei, Caimiao, Lee, J. Jack, Hong, David S., Eggermont, Alexander M., Schilsky, Richard L., Mendelsohn, John, Lazar, Vladimir, Kurzrock, Razelle
Publicat a J Natl Cancer Inst (2015)

FBXW7 Mutations in Patients with Advanced Cancers: Clinical and Molecular Characteristics and Outcomes with mTOR Inhibitors

per Jardim, Denis L., Wheler, Jennifer J., Hess, Kenneth, Tsimberidou, Apostolia M., Zinner, Ralph, Janku, Filip, Subbiah, Vivek, Naing, Aung, Piha-Paul, Sarina A., Westin, Shannon N., Roy-Chowdhuri, Sinchita, Meric-Bernstam, Funda, Hong, David S.
Publicat 2014

MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors

per Tang, Chad, Fontes Jardim, Denis L., Falchook, Gerald S., Hess, Kenneth, Fu, Siqing, Wheler, Jennifer J., Zinner, Ralph G., Naing, Aung, Tsimberidou, Apostolia M., De Melo Galgiato, Debora, Westin, Shannon N., Meric-Bernstam, Funda, Kurzrock, Razelle, Hong, David S.
Publicat a Oncoscience (2013)

SARS-CoV-2 testing for asymptomatic adult cancer patients before initiating systemic treatments: a systematic review

per Haradaa, Guilherme, Antonacio, Fernanda F, Gongora, Aline BL, Behar, Marina H, Capareli, Fernanda C, Bastos, Diogo A, Munhoz, Rodrigo R, Costa, Frederico P, Jardim, Denis L, Arrais-Rodrigues, Celso, Novis, Yana, Katz, Artur, de Castro Junior, Gilberto
Publicat a Ecancermedicalscience (2020)

Analysis of MET Genetic Aberrations in Patients With Breast Cancer at MD Anderson Phase I Unit

per de Melo Gagliato, Debora, Fontes Jardim, Denis L., Falchook, Gerald, Tang, Chad, Zinner, Ralph, Wheler, Jennifer J., Janku, Filip, Subbiah, Vivek, Piha-Paul, Sarina A., Fu, Siqing, Hess, Kenneth, Roy-Chowdhuri, Sinchita, Moulder, Stacy, Gonzalez-Angulo, Ana M., Meric-Bernstam, Funda, Hong, David S.
Publicat a Clin Breast Cancer (2014)

MET abnormalities in patients with genitourinary malignancies and outcomes with c-MET inhibitors

per Jardim, Denis L. F., de Melo Gagliato, Débora, Falchook, Gerald, Zinner, Ralph, Wheler, Jennifer J., Janku, Filip, Subbiah, Vivek, Piha-Paul, Sarina A., Fu, Siqing, Tannir, Nizar, Corn, Paul, Tang, Chad, Hess, Kenneth, Roy-Chowdhuri, Sinchita, Kurzrock, Razelle, Meric-Bernstam, Funda, Hong, David S.
Publicat a Clin Genitourin Cancer (2014)